Clinical Trial Update: A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a house dust mite sublingual immunotherapy tablet for allergic rhinitis/rhinoconjunctivitis in Chinese participants aged 12-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• ACARIZAX (house dust mite sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinoconjunctivitis, Allergic Rhinitis | Phase 3 | Status: RECRUITING